@article{JTD2838,
author = {Simone de Leon Martini and Carolina Beatriz Müller and Rosalva Thereza Meurer and Marilda da Cruz Fernandes and Rodrigo Mariano and Mariel Barbachan e Silva and Fábio Klamt and Cristiano Feijó Andrade},
title = {The potential role of extracellular regulatory kinase in the survival of patients with early stage adenocarcinoma},
journal = {Journal of Thoracic Disease},
volume = {6},
number = {7},
year = {2014},
keywords = {},
abstract = {Background: Lung cancer is among the most common types of neoplasias, and adenocarcinoma is the most frequent histological type. There is currently an extensive search for prognostic biomarkers of nonsmall cell lung cancer (NSCLC).
Methods: We analyzed the correlation of clinical data and patient survival with the levels of activated extracellular regulatory kinase (ERK) in histological samples of surgically resected early stage lung adenocarcinoma. We randomly selected 36 patients with stage I or II lung adenocarcinoma who underwent pulmonary lobectomy between 1998 and 2004. Patients were divided into the following two groups according to immunohistochemical profile: a group with },
issn = {2077-6624}, url = {https://jtd.amegroups.org/article/view/2838}
}